DePuy Synthes, a global leader in orthopaedic technologies and solutions, today announced the appointment of Christina ...

Johnson & Johnson’s DePuy Synthes Orthopaedics business today announced the appointment of Christina Zamarro as its new CFO.

Christina Zamarro will take over the role in July after spending nearly 20 years at Goodyear Tire & Rubber Company, most recently serving as its CFO.

The orthopedic surgical robots market presents growth opportunities in AI integration, digital workflows, and minimally ...

RAYNHAM, Mass., Aug. 18, 2021 /PRNewswire/ -- Today, The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson,** introduces the ...

DePuy Synthes Companies is offering health care professionals a new way to track and analyze patient data in real-time and a new program to improve patients' experience with joint replacement surgery.

DePuy Synthes employees perform wax injection assembly for foundry casting. On a recent Tuesday in Raynham, Mass., Jerry, a retired mechanical engineer, stood in front of an assembled group and talked ...

DePuy Synthes CMF (Craniomaxillofacial), a leader in skeletal and soft tissue repair and reconstruction and part of the DePuy Synthes Companies of Johnson & Johnson, has launched Patient Specific ...

Agreement will bring first-to-market capabilities to eliminate line-of-sight dependency designed to improve simplicity and surgical flow DePuy Synthes, a global leader in orthopaedic technologies and ...

DePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa (EMEA). The implants are designed to provide ...

Johnson & Johnson’s (NYSE:JNJ) DePuy Synthes Spine is expanding its reach in the spine market with U.S. Food and Drug Administration clearance of three of its systems for use in adolescents with ...

Codman & Shurtleff Inc., part of the Depuy Synthes companies, announced Tuesday that it has received a premarket approval from the U.S. Food and Drug Administration to market a neuromodulation product ...